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Heme oxygenase 1 (Hmox1), a ubiquitous enzyme degrading heme to carbon monoxide, iron, and biliverdin, is one of the
cytoprotective enzymes induced in response to a variety of stimuli, including cellular oxidative stress. Gangliosides, sialic acid-
containing glycosphingolipids expressed in all cells, are involved in cell recognition, signalling, and membrane stabilization.
Their expression is often altered under many pathological and physiological conditions including cell death, proliferation, and
diﬀerentiation. The aim of this study was to assess the possible role of Hmox1 in ganglioside metabolism in relation to oxidative
stress. The content of liver and brain gangliosides, their cellular distribution, and mRNA as well as protein expression of key
glycosyltransferases were determined in Hmox1 knockout mice as well as their wild-type littermates. To elucidate the possible
underlying mechanisms between Hmox1 and ganglioside metabolism, hepatoblastoma HepG2 and neuroblastoma SH-SY5Y cell
lines were used for in vitro experiments. Mice lacking Hmox1 exhibited a signiﬁcant increase in concentrations of liver and
brain gangliosides and in mRNA expression of the key enzymes of ganglioside metabolism. A marked shift of GM1 ganglioside
from the subsinusoidal part of the intracellular compartment into sinusoidal membranes of hepatocytes was shown in Hmox1
knockout mice. Induction of oxidative stress by chenodeoxycholic acid in vitro resulted in a signiﬁcant increase in GM3, GM2,
and GD1a gangliosides in SH-SY5Y cells and GM3 and GM2 in the HepG2 cell line. These changes were abolished with
administration of bilirubin, a potent antioxidant agent. These observations were closely related to oxidative stress-mediated
changes in sialyltransferase expression regulated at least partially through the protein kinase C pathway. We conclude that
oxidative stress is an important factor modulating synthesis and distribution of gangliosides in vivo and in vitro which might
aﬀect ganglioside signalling in higher organisms.
1. Introduction
Heme oxygenase 1 (Hmox1) is a highly inducible antioxi-
dant and cytoprotective enzyme in the heme catabolic
pathway generating equimolar amounts of iron, carbon
monoxide, and biliverdin which is immediately reduced
to bilirubin [1]. Hmox1 activity—also due to the eﬀect of
its bioactive products—aﬀects pathophysiology of many
neurologic, cardiovascular, and pulmonary diseases [2–4].
In the liver, Hmox1 plays an important role in hepatic
fat accumulation, ﬁbrogenesis, ischemia-reperfusion, and
oxidative injury [5]. Moreover, upon Hmox1 knockout,
the cells and/or animals becomemore vulnerable to oxidative
stress. Free radical formation as well as oxidative stress-
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associated cytotoxicity are increased inHmox1 knockouts due
to reduced antioxidant bilirubin and vasoactive carbon mon-
oxide formation, disruption of iron homeostasis, and
accumulation of prooxidative heme [6]. Due to iron accumu-
lation, liver is one of the tissues most aﬀected by an increased
oxidative stress in Hmox1 knockout mice and increased lipid
peroxidation, ﬁbrosis, and hepatic injury have been described
in these animals [5]. Furthermore, an increase in some key
cytoprotective genes such as NAD(P)H dehydrogenase qui-
none 1 and glutathione S-transferase P1 andmarked decrease
in peroxyl radical scavenging activity have been described in
Hmox1 knockouts even under basal (unstimulated) condi-
tions [7]. Bilirubin per se is considered a potent endogenous
antioxidant protecting against diseases associated with oxida-
tive stress [8] and counteracting harmful eﬀects of various
prooxidants including hydrophobic bile acids (BA) on cells
and tissues [9]. In fact, both bilirubin and BA are accumulated
in plasma and tissues during cholestasis and while BA are
responsible for increased lipid peroxidation and oxidative
liver damage, bilirubin has a protective eﬀect [10].
Gangliosides are ubiquitously found in all tissues, butmost
abundantly in the nervous system [11]. They substantially
inﬂuence the organization of the membrane and the function
of speciﬁc membrane-associated proteins due to lipid-lipid
and lipid-protein lateral interactions [12]. In the brain, gan-
glioside expression correlates with neurogenesis, synapto-
genesis, synaptic transmission, and cell proliferation [13, 14].
It is known that gangliosides form so called caveolae or
“detergent resistantmicrodomains” (DRM), which are crucial
elements for cell-cell recognition, adhesion, and especially
membrane stabilization [15, 16]. There is also evidence that
caveolin-1, an important component of caveolae, interacts
with Hmox1, modulates its activity, and can act as a natural
competitive inhibitor of Hmox1 with heme [17]. Moreover,
gangliosides have been found to inhibit hydroxyl radical for-
mation in vitro [18] and also modulate ROS formation in
human leukocytes [19] and neuronal cells [20].
Despite the close relationship of gangliosides and
Hmox1 in DRM, there are only few reports discussing
the possible role of Hmox1 or oxidative stress in ganglioside
metabolism [21, 22]. The aim of this study was to assess
the role of Hmox1 knockout and associated oxidative
stress on ganglioside metabolism and to identify the possible
underlying mechanisms.
2. Materials and Methods
2.1. Materials. Paraformaldehyde, biotin, bovine serum
albumin (BSA), phorbol 12-myristate 13-acetate (protein
kinase C (PKC) activator), Ro 31-0432 (PKC inhibitor),
chenodeoxycholic acid (CDCA), diaminobenzidine tetrahy-
drochloride tablets, NADPH, and sulfosalicylic acid were
supplied by Sigma-Aldrich (St. Louis, MO, USA); avidin
was obtained from Fluka (Buchs, Switzerland), the cholera
toxin B subunit (CTB) peroxidase conjugated came from List
Biological Laboratories (CA, USA), and the HPTLC silica-gel
plates came from Merck (Darmstadt, Germany). Cell plates
were supplied by Corning (NY, USA). The TaqMan® Gene
Expression Master Mix, High-Capacity RNA-to-cDNA Kit,
and the TaqMan Gene Expression Assay kit for mouse
and human genes were obtained from Life Technologies
(Carlsbad, CA, USA). The QIAshredder kit and RNeasy
Plus Mini Kit were supplied by Qiagen (USA). All other
chemicals were purchased locally from Penta (Prague,
Czech Republic).
2.2. Animals. Hmox1−/− (n = 9; KO—knockout) mice and
Hmox1+/+ (n = 6; Wt—wild type) littermates (C57Bl/6xFVB,
8-week-oldmales) were used for all the experiments. Breeding
heterozygote pairs of Hmox1-deﬁcient mice were initially
kindly provided by Anupam Agarwal, University of Alabama
(Birmingham, AL). The Hmox1−/− strain poorly breeds on
pure C57/Bl6 background (5.1% of expectedHmox1−/− pups)
and therefore is maintained on mixed C57/Bl6×FVB back-
ground (20.1% of expected Hmox−/− pups, when Hmox−/−
males are crossed with Hmox+/− females) [23]. All Hmox1+/+
controls were C57/Bl6xFVB littermates from the same
breeders used to obtain Hmox1−/− mice. They had free
access to food and water and were kept in individually
ventilated cages with a 12:12 day/night cycle, under a spe-
ciﬁc pathogen-free regime. All aspects of the study met
the accepted criteria of experimental use of laboratory ani-
mals, and all protocols were approved by the Animal
Research Committee of the 1st Faculty of Medicine, Charles
University, Prague, Czech Republic, and by the 1st Local
Ethics Committee for Animal Research, Krakow, Poland.
2.3. Tissue Preparation.Mice were intraperitoneally anesthe-
tized with ketamine (90mg/kg) and xylazine (10mg/kg) and
sacriﬁced by cervical dislocation at day 5. The inferior vena
cava was cannulated through laparotomy, and blood samples
were collected, transferred to EDTA-containing tubes, mixed,
and placed on ice. An aliquot was centrifuged to separate out
the plasma. The livers and brains were then harvested and
weighed. Pieces of liver tissues were appropriately proc-
essed for further biochemical and histochemical analyses
(see below). For quantitative histochemical analysis of GM1
ganglioside, the liver specimens were collected using a
systematic uniform random sampling method [24].
For the RNA analysis, 100mg of tissue was immediately
placed in 1.5mL microcentrifuge tubes containing RNAlater
(Qiagen, Valencia, CA, USA). The tubes were stored at −80°C
until total RNA isolation.
2.4. Extraction and TLC Densitometry of Liver and Brain
Gangliosides. The chloroform-methanol extraction of gangli-
osides from the liver tissue was used—the procedure previ-
ously described by Majer et al. [25]—and gangliosides were
ﬁnally puriﬁed on a small silica gel column [26]. Brain gangli-
osides were isolated as described previously [27, 28]. All
ganglioside samples were separated in a solvent system
(chloroform/methanol/0.2% aqueous CaCl2, 55/45/10, v/v/v)
and detected with resorcinol-HCl reagent. The densitometry
was performed according to Majer et al. [25] using a CATS3
Software, CAMAG (Switzerland).
GSL are abbreviated according to recommendations of
the IUPAC-IUB Commission on Biochemical Nomencla-
ture [29]: glycosyltransferases: GlcT, UDP-glucose ceramide
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glucosyltransferase; GalTI, UDP-Gal:betaGlcNAc beta-1,4-
galactosyltransferase; ST3GalV (GM3 synthase), ST3 beta-
galactoside alpha-2,3-sialyltransferase 5; ST8SiaI (GD3
synthase), ST8 alpha-N-acetylneuraminide alpha-2,8-sialyl-
transferase 1; B4GalNTI (GM2/GD2 synthase), beta-1,4-N-
acetyl-galactosaminyltransferase 1; and B3GalTIV (GM1
synthase), UDP-Gal:betaGlcNAcbeta 1,3-galactosyltransferase.
2.5. GM1 Histochemistry. GM1 was determined using a
modiﬁed procedure according to Jirkovská et al. [30]. In
brief, 4% formaldehyde was freshly prepared by depolymeri-
zation of paraformaldehyde (pH = 7 2). Frozen 6μm thin
sections were ﬁrst ﬁxed in dry cold acetone (−20°C) for
15min and then in 4% freshly prepared paraformaldehyde
for 5min. Endogenous peroxidase activity was blocked by
incubation for 15min in phosphate-buﬀered saline (PBS)
supplemented by 1% H2O2 and 0.1% sodium azide. Endoge-
nous biotin was blocked by means of a DakoCytomation
blocking kit (DakoCytomation, Denmark). In order to block
nonspeciﬁc binding, sections were treated with 3% BSA in
PBS for 15min. GM1 ganglioside was detected in liver sec-
tions using CTB biotin labelled (Sigma, USA), diluted 1:300
in PBS, plus 3% BSA at 8°C for 16.5 h, followed with
streptavidin-peroxidase polymer at room temperature for
1 h. Peroxidase activity was visualized with diaminobenzi-
dine tetrahydrochloride for 20min in the dark. Sections were
mounted in mounting medium Dako S3025 (Dako North
America, CA, USA).
Two negative control tests were performed for each
group. First, CTB was omitted in immunohistochemical
staining. Second, ﬁxed sections were extracted with chloro-
form :methanol 2:1 at room temperature for 30 minutes
followed by standard immunohistochemical staining.
2.6. Densitometric Analysis of GM1 Ganglioside in Sinusoidal
Membrane and Adjacent Cytoplasm Areas. Six liver speci-
mens were used from each animal. One section from each
specimen was used for GM1 ganglioside detection with
CTB as described above. From each section, four hepatic lob-
ules with a clearly discernible central vein were selected. In
each lobule, one measuring frame in the central lobular zone
III and one measuring frame in the corresponding peripheral
lobular zone I were selected for analysis. In each frame,
15 areas of sinusoidal surface and 15 areas of adjacent hepato-
cyte cytoplasm were selected by the stratiﬁed random sam-
pling method [24] and marked out. The reaction product
was quantiﬁed as the mean optical density of the analyzed
areas (determined by the densitometric program ACC 6.0,
SOFO, Czech Republic) at objective magniﬁcation of 40x
(NA = 0 7). The ratios of densities measured in the sinusoidal
membrane and subsinusoidal intracellular compartment
were measured and compared together (sin/int).
2.7. Cell Culture Experiments. Human neuroblastoma cell
line SH-SY5Y (ATCC, Manassas, VA, USA) was cultured in
the Minimum Essential Medium Eagle (MEM) and Ham’s
F-12 medium (1:1, v/v) with 15% of fetal bovine serum and
human hepatoblastoma cell line HepG2 (ATCC, Manassas,
VA, USA) in MEM with 10% of fetal bovine serum in a
humidiﬁed atmosphere (containing 5% CO2 and 37
°C).
Authentication of used cell lines was conﬁrmed by an inde-
pendent laboratory using a method based on an accredited
short tandem repeat analysis.
Cells were seeded onto 6-well plates (Corning, NY, USA)
at a concentration of 50,000 cells per 1 cm2 and treated with
CDCA and bilirubin for 4 h. SH-SY5Y cells were also treated
with PKC activator (phorbol 12-myristate 13-acetate) or
PKC inhibitor (Ro 31-0432) for 4 h. After the incubation
period, cells were harvested into the lysis buﬀer and stored
at −80°C for further experiments.
2.8. Measurement of Intracellular ROS Production. ROS pro-
duction was determined using a ﬂuorescent probe 5-(and-6)-
chloromethyl-2′,7′-dichlorodihydroﬂuorescein diacetate
acetyl ester (CM-H2DCFDA, Life Technologies, USA).
Brieﬂy, SH-SY5Y cells were grown in 12-well plates to 80%
conﬂuence. Cells were then incubated with CDCA and/or
antioxidant (bilirubin) for 24 h. After the incubation, the
cells were washed twice with PBS and loaded with 10μM
CM-H2DCFDA at 37°C for 30min in the dark, then washed
with PBS to remove excess dye. Fluorescence was measured
using 485nm excitation and 540nm emission wavelengths
inmicroplate reader (Synergy HTX, BioTek, USA). Cells were
then lysed with Cell Lysis Buﬀer (Cell Signaling Technology,
USA), and protein concentration was measured using DC
Protein Assay (Bio-Rad, USA) according to the manufac-
turer’s instruction. Data were normalized to protein content
and expressed as % of controls.
2.9. Lipid Peroxidation. Lipid peroxidation was measured
according to the method by Vreman et al. [31]. Twenty
microliters of 10% liver or brain sonicates in 0.1M phosphate
buﬀer, pH = 7 4, were incubated at 37°C with 100μM ascor-
bate (80μL) and 6μM Fe2+ (0.5μL) in a septum-sealed vial.
Butylated hydroxytoluene (10μM) was added to the blank
reaction. The reaction was terminated by adding 2μL of
60% sulfosalicylic acid. CO produced into the vial headspace
was quantiﬁed by gas chromatography with a reduction gas
analyzer (Peak Laboratories LLC, Mountain View, CA,
USA). The amount of CO produced served as an index of
lipid peroxidation, was measured as picomoles of CO per
hour per milligram of fresh tissue, and was expressed as %
of control.
2.10. Western Blotting. Cells grown to 60% conﬂuency were
lysed using RIPA buﬀer supplemented with phosphatase
and protease inhibitors (Protease Inhibitor Mix G and
Phosphatase Inhibitor Mix I, Serva, Heidelberg, Germany).
Samples were separated by SDS-PAGE on 12% polyacryl-
amide gel and then transferred to nitrocellulose membrane
(Bio-Rad Laboratories, Hercules, CA, USA). After blocking
in Tween-PBS with 5% BSA (Sigma-Aldrich, St. Louis, MO,
USA) for at least 1.5 h, membranes were incubated with
GM3 synthase and GM2/GD2 synthase antibody (1:2000;
Santa Cruz sc-365329 and sc-376505, Dallas, TX, USA), or
β-actin (1:2000; Cell Signaling Technology, Danvers, MA,
USA) overnight at 4°C. After washing, membranes were
incubated with anti-mouse m-IgGκ BP-HRP (Santa Cruz
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sc-516102, Dallas, TX, USA) for 1 h. Immunocomplexes on
the membranes were visualized with ECL Western Blotting
Detection Reagents (Cell Signaling Technology) using an
Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln, NE, USA).
2.11. Quantitative Real-Time PCR. The liver samples were
stored frozen at −80°C in RNAlater (Sigma-Aldrich, St.
Louis, USA), and total RNA was isolated using a Qiagen
RNAeasy Plus kit and QIAshredder (Qiagen, USA). Cell cul-
ture samples were stored in lysis buﬀer at −80°C, and total
RNA was isolated using PerfectPure RNA Cell Kit (5Prime,
USA). A High-Capacity cDNA Reverse Transcription Kit
(Life Technologies, Carlsbad, CA, USA) was used to gener-
ate cDNA. Quantitative real-time PCR was performed using
TaqMan® Gene Expression Assay Kit (Life Technologies,
Carlsbad, CA, USA) for the following genes: GlcT
(Hs00234293_m1), GalTI (Hs00191135_m1), GM3 synthase
(St3GalV, Mm00488237_m1, and Hs01105379_m1), GD3
synthase (STSia8, Mm00456915_m1, and Hs00268157_m1),
GM2/GD2 synthase (B4GalNT1, Mm00484653_m1,
and Hs01110791_g1), and GM1 synthase (B3GalT4,
Mm00546324_s1, and Hs00534104_s1), all provided by Life
Technologies (Carlsbad, CA, USA). The data were normal-
ized to HPRT and expressed as percent of control levels.
2.12. Statistical Analysis. Normally distributed data are pre-
sented as mean ± SD and analyzed by the Student t-test.
The Mann–Whitney U test or Kruskal-Wallis test were used
in skewed data. Diﬀerences with P < 0 05 were considered
signiﬁcant.
3. Results
3.1. The Impact of Hmox1 Knockout on the Liver and Brain
Ganglioside Content. To investigate the role of Hmox1
knockout on the ganglioside pattern, we measured changes
in ganglioside composition in the liver as well as the brain,
the tissue with the highest glycolipid content in vivo. As the
ganglioside spectra diﬀer within speciﬁc tissues, only major
gangliosides and representatives of two main biosynthetic
pathways, a- and b-series, were determined.
In the liver, mice lacking Hmox1 exhibited marked
increases in the concentrations of individual gangliosides.
Speciﬁcally, Hmox1 knockout led to a signiﬁcant increase
in GM3 (343± 76%, P < 0 001) and GM1 (265± 62%,
P < 0 001) representing a-series, and GD1b (582± 176%,
P < 0 001) from b-series of gangliosides (Figure 1(a)).
In the brain, the most abundant ganglioside was GD1a in
both wild-type as well as knockout animals. Together with
GM1, GD1a content was signiﬁcantly higher (GD1a 122%
vs. Wt, P < 0 05; GM1 140% vs. Wt, P < 0 05) in Hmox1
knockout mice as compared to wild types. The other two
major brain gangliosides (GM3, GT1b) stayed unchanged
after Hmox1 knockout. The amount of minor GD3 ganglio-
side was also signiﬁcantly increased (154% vs. Wt, P < 0 01)
(Figure 1(b)). The scheme of de novo biosynthesis of
the oligosaccharide moieties of gangliosides is illustrated in
Figure 2.
To conﬁrm the level of oxidative stress in Hmox1 knock-
outs, we measured the extent of lipid peroxidation in liver
and brain tissue homogenates. Importantly, liver lipid perox-
idation was increased in Hmox1 knockout mice as compared
to controls (155%± 51% Hmox−/−, n = 7, vs. 100%± 46%
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Figure 1: The impact of Hmox1 knockout on ganglioside composition in mouse (a) liver and (b) brain. Isolated hepatic (a) and brain (b)
gangliosides were separated in a solvent system and analyzed by a densitometric method after TLC separation and detection using
resorcinol-HCl reagent. Values are expressed as % of control and represent mean SD. Wt: wild-type (n = 6); KO: Hmox1 knockout (n = 9).
∗P < 0 05 and ∗∗P < 0 01.
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Figure 2: Hmox1 knockout leads to changes in sialyltransferase expression in the liver and brain. Relative mRNA expression of the key
enzymes in ganglioside synthesis was measured in the liver (a) and brain (b) tissues of wild-type (Wt) and Hmox1 knockout (KO)
animals. Values are expressed as % of control. Wt: wild-type (n = 6); KO: Hmox1 knockout (n = 9). ∗P < 0 01; ∗∗P < 0 001.
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Hmox+/+, n = 6, P = 0 032). No signiﬁcant increase was
observed in a brain tissue (115%± 46% Hmox−/−, n = 7, vs.
100%± 45% Hmox+/+, n = 6, P = 0 311).
3.2. Hmox1 Knockout Results in Changes in the Expression of
Sialyltransferases. Relative mRNA expression of the key sia-
lyltransferases was determined to elucidate the activation rate
of a- and b-series of a ganglioside biosynthetic pathway in
mouse liver and brain homogenates. Hmox1 knockout led
to a signiﬁcant increase in mRNA expression of GM3
synthase (ST3GalV) (287± 55%, P < 0 001; 183± 41%,
P < 0 01) in both liver and brain, and GD3 synthase
(St8SiaI) (224± 89%, P < 0 01), the key step in an activation
of b-biosynthetic branch in the liver. Hmox1 knockout
caused also signiﬁcant activation of GM2/GD2 synthase
(B4GalNTI) (538± 121%, P < 0 001) in the liver. Expression
of GM1 synthase (B3GalTIV) stayed unchanged in both liver
and brain (Figure 2).
3.3. Hmox1 Knockout Leads to a Marked Shift of Gangliosides
to the Hepatocyte Membrane. To study possible changes
in distribution of gangliosides within mouse hepatocytes,
histochemical localization of GM1, the representative of
gangliosides, was determined in the liver sections. In con-
trol liver specimens, GM1 was detected in both sinusoidal
and canalicular membranes, as well as in the intracyto-
plasmic compartment. In Hmox1 knockout animals, we
observed a pronounced shift in GM1 ganglioside expression
from intracellular localization into sinusoidal membranes
(Figure 3(a)). To quantify this redistribution pattern of
GM1, we measured the GM1 expression under high micro-
scopic magniﬁcation expressed as sin/int ratio (GM1 staining
in the sinusoidal membrane/subsinusoidal intracellular com-
partment) (133± 7%, P < 0 01, Figure 3(b)).
3.4. Ganglioside Pattern in Neuroblastoma Cells (SH-SY5Y) Is
Aﬀected by Oxidative Stress. To ﬁnd out whether changes in
the ganglioside pattern might be aﬀected by an increased
oxidative stress associated withHmox1 knockout, we investi-
gated the regulation of glycosphingolipid (GSL) synthesis
using SH-SY5Y neuroblastoma cells rich in gangliosides.
CDCA, a potent inducer of ROS production accumulating
in the liver during cholestasis, was used to increase oxidative
stress in vitro, while addition of bilirubin, a potent antioxi-
dant and a product of the Hmox pathway, had an opposite
eﬀect (Figure 4).
Administration of CDCA (80μM) resulted in a signiﬁ-
cant increase in the major gangliosides GD1a (141%,
P < 0 01), GM3 (170%, P < 0 01), and GM2 (130%, P < 0 05)
in SH-SY5Y neuroblastoma cells (Figure 5(a)) and GM3
(233%, P < 0 01) and GM2 (251%, P < 0 05) in hepatoblas-
toma HepG2 cells (Figure 5(b)). Interestingly, coadministra-
tion of bilirubin (CDCA/bilirubin), a potent antioxidant,
resulted in normalization of the ganglioside pattern in both
cell lines (Figure 5).
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Figure 3: The eﬀect of Hmox1 knockout on distribution/localization of GM1 ganglioside in the liver. (a) Immunohistochemical detection of
GM1 ganglioside. In the liver sections, GM1 ganglioside was detected using the cholera toxin B subunit with streptavidin-peroxidase polymer.
Diaminobenzidine tetrahydrochloride (brown colour) was used for visualization. The shift of GM1 ganglioside expression from intracellular
localization (white arrows) into sinusoidal membranes (black arrows) was observed in Hmox1 knockout animals. (b) Quantiﬁcation of GM1
staining in the liver. Image analysis of the distribution of GM1 ganglioside staining in the subsinusoidal part of the intracellular compartment
(int) and sinusoidal membranes (sin) of hepatocytes, expressed as the sin/int ratio relative to control (Wt). The reaction product was
quantiﬁed as the mean optical density of the analyzed areas at objective magniﬁcation of 40x (NA = 0 7). Bar represents 100μm.
Wt: wild-type (n = 6); KO: Hmox1 knockout (n = 9). ∗∗P < 0 01.
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3.5. Oxidative Stress-Mediated Changes in Sialyltransferase
(ST3GalV) Expression Are Regulated through the Protein
Kinase C Pathway. To elucidate whether oxidative stress
induced by CDCA aﬀects the expression of GM3 synthase
(ST3GalV), a key enzyme in ganglioside metabolism,
in vitro, SH-SY5Y as well as HepG2 cell lines were incubated
with CDCA and/or bilirubin for 4 h. Signiﬁcant increases in
GM3 synthase mRNA expression were observed upon
CDCA treatment while cotreatment with bilirubin abolished
this eﬀect in both neuroblastoma (Figure 6(a)) and hepatic
(Figure 6(c)) cell lines. The results were conﬁrmed by
the detection of GM3 synthase protein expression in the
SH-SY5Y cell line (Figure 6(b)).
To investigate the possible role of the PKC pathway on
oxidative stress-mediated changes in ganglioside expres-
sion, we measured the eﬀect of PKC induction/inhibition
(PKC+/−) on the mRNA expression of GM3 synthase
(ST3GalV), in the SH-SY5Y cell line. PKC activators
induced the mRNA expression of ST3GalV. On the other
hand, PKC inhibitors signiﬁcantly decreased ST3GalV
mRNA expression. Importantly, cotreatment of CDCA
with PKC inhibitor completely abolished the stimulatory
eﬀect of CDCA on ST3GalV mRNA (Figure 6(d)). Suc-
cessful PKC activation and/or inhibition was proven by
determination of mRNA expression of PKC alpha, PKC
beta, and PKC epsilon (Figure 6(e)).
4. Discussion
Gangliosides play a crucial role in signal transduction
pathways, regulating many diﬀerent cell functions such
as proliferation, diﬀerentiation, adhesion, and cell death
[32, 33]. They are responsible for the rigidity of a plasmatic
membrane [34] and participate in a protection against
oxidative stress [19, 21]. However, the signiﬁcance of changes
in ganglioside metabolism under oxidative stress remains to
be elucidated. To address this issue, we have studied the con-
sequences of the antioxidant enzyme Hmox1 deﬁciency for
ganglioside metabolism in mouse tissues. Unlike in the brain,
we found signiﬁcantly increased lipid peroxidation in the
liver of Hmox1 knockout animals which is in accordance
with the published data showing increased lipid peroxidation
and hepatic injury mostly due to iron accumulation in the
liver tissue [6]. Our results indicate that oxidative stress plays
an important role in ganglioside synthesis resulting in
changes in their spectra and cellular distribution.
Gangliosides are ubiquitously found in tissues and body
ﬂuid with the most abundant expression in the nervous
system [35]. The expression levels of gangliosides undergo
dramatic changes during various physiological and patholog-
ical conditions including cell death, proliferation, diﬀerentia-
tion, development, and oncogenesis [36–38] as well as
neurological diseases [39, 40]. These eﬀects are largely attrib-
uted to the changes in expression levels of ganglioside
synthases (glycosyltransferases) [41, 42]. In our previous
experiments on rats, we observed the shift in liver ganglioside
synthesis towards more complex ones in various types of
cholestatic liver diseases [25, 30]. These changes were associ-
ated with the accumulation of detergent and prooxidative
bile acids as well as with the increase in oxidative stress in
these animals [21, 22].
In the present study, Hmox1 knockout resulting in the
absence of an important antioxidant enzyme in experimental
mice was accompanied by signiﬁcant increases in the brain
GM1, GD1a, and GD3 and liver GM1, GM3, and GD1b gan-
gliosides. The tissue speciﬁcity of these changes might be
explained by the diﬀerent ganglioside composition of the
liver and brain tissues. While GM3 is the main ganglioside
in the liver, GD1a is the most abundant in the adult brain
[38, 43], where GD1a, GM1, GD1b, GT1b, and GD3 belong
to most important glycosphingolipids [44]. Several reports
suggest gangliosides to possess antioxidant properties, but
very little is known about the function of gangliosides in
the liver and therefore most data relates to the nervous
tissue [11]. Among these, GM1 ganglioside has neuropro-
tective functions. Micelles containing GM1 inhibited iron-
catalysed hydroxyl radical formation in vitro [18], GM1
decreased ROS formation in rat brain synaptosomes [45],
or protected cells against H2O2-induced oxidative damage
[46] while GD1b was able to inhibit lipid peroxidation in
human sperm cells [47]. On the other hand, some gangli-
osides might enhance ROS formation and contribute to
the cell death. Sohn et al. [48] found GM3, but not GD3
or GT1b, to mediate oxidative toxicity induced by gluta-
mate in immortalized mouse neuronal HT22 cells. GD3
was described to interact with mitochondria and generate
ROS [49, 50], and there is strong evidence for involvement
of GD3 in autophagosome formation [51, 52]. GD3 is also
considered a key player in apoptosis by Fas, ceramide, and
amyloid-β [53, 54]. These ﬁndings suggest an important
role of gangliosides in processes involved in oxidative stress
regulation which might explain their compensatory upregu-
lation in the prooxidative environment of Hmox1 knockout.
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Figure 4: The ameliorating eﬀect of bilirubin on CDCA-induced
oxidative stress in SH-SY5Y cells. SH-SY5Y cells were incubated
with CDCA (80 μM), bilirubin (1 μM), or both (CDCA/bilirubin)
for 24 h. ROS production was measured using ﬂuorescent
CM-H2DCFDA probe. Values are expressed as % of controls.
C: control; CDCA: chenodeoxycholic acid (80 μM); bilirubin: 1 μM
bilirubin; CDCA/bilirubin: CDCA (80 μM)+ bilirubin (1 μM).
∗P < 0 05 vs. C; †P < 0 05 vs. CDCA.
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The eﬀect of oxidative stress on changes in ganglioside
synthesis was further supported by determination of glyco-
syltransferase mRNA expressions in mouse liver and brain
homogenates. The key regulatory enzymes in the synthesis
of nearly all gangliosides, GM3 and GD3 synthases, as well
as GalNAcT, were found to be signiﬁcantly increased in
Hmox1 knockouts while GM1 synthase expression stayed
unchanged. These data correspond with the observed
increases in liver gangliosides and are in accordance with
our previous observations on liver glycosyltransferase
expression in experimental cholestasis in rats [22]. The
increase in liver GM1 ganglioside content in Hmox1 knock-
outs allows speculating that expression of GM1 synthase is
redundant in wild-type animals and is capable of maintain-
ing the induction of the GalNAcT product. Interestingly,
only GM3 synthase has been found to be signiﬁcantly upreg-
ulated in the brain suggesting the tissue-speciﬁc regulation
of various sialyltransferases. Moreover, diﬀerent extents of
oxidative stress in particular tissues might aﬀect the ﬁnal
sialyltransferase expression.
Furthermore, in our earlier reports, we described not only
an increase in ganglioside synthesis but also their shift into
the sinusoidal membranes of hepatocytes upon oxidative
stress induced by bile acids [21]. This mechanism could pro-
tect hepatocytes against detergent and prooxidant eﬀects of
bile acids. A very similar eﬀect was observed in the present
study. We have used a selective histochemical approach
based on the high binding aﬃnity of Cholera toxin B subunit
to GM1 ganglioside [6], the representative of the complex
gangliosides. A signiﬁcant shift of GM1 gangliosides from
intracellular localization to the membrane compartment
was found in Hmox1 knockout which is also associated with
prooxidative condition.
To investigate the mechanism of oxidative stress-
mediated changes in ganglioside metabolism, we used the
in vitro model of the SH-SY5Y neuroblastoma cell line rich
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Figure 5: The ameliorating eﬀect of bilirubin on CDCA-induced change in ganglioside content in SH-SY5Y cells (a) and HepG2 cells (b).
Relative content of individual gangliosides was evaluated using extraction and TLC densitometry after incubation with CDCA or CDCA/
bilirubin for 4 in (a) SH-SY5Y cells and (b) HepG2 cells. Values are expressed as % of controls. Bilirubin (1 μM); CDCA: chenodeoxycholic
acid (80 μM); CDCA/bilirubin: CDCA (80 μM)+ bilirubin (1 μM). ∗P < 0 05 vs. C; ∗∗P < 0 01 vs. C; +P < 0 05 vs. CDCA; ++P < 0 01 vs. CDCA.
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Figure 6: The opposite eﬀects of CDCA and bilirubin on regulation of GM3 synthase expression in SH-SY5Y and HepG2 cells. (a) Relative
GM3 synthase (ST3GalV) mRNA expression was determined in control cells (C), after 4 h incubation with chenodeoxycholic acid (CDCA)
and/or bilirubin in SH-SY5Y cells. (b) Relative GM3 synthase (ST3GalV) protein expression by Western blot was determined in control cells
(C), after 4 h incubation with chenodeoxycholic acid (CDCA) and/or bilirubin in SH-SY5Y cells. (c) Relative GM3 synthase (ST3GalV)
mRNA expression was determined in control cells (C), after 4 h incubation with chenodeoxycholic acid (CDCA) and/or bilirubin in
HepG2 cells. (d) PKC activity was modulated by incubating SH-SY5Y cells with PKC activator (PKC+) or PKC inhibitor (PKC−) or their
combination with CDCA (CDCA/PKC+, CDCA/PKC−) for 4 h. (e) PKC activation and/or inhibition was proven by determination of
mRNA expression vs. control (100% line) of PKC alpha, PKC beta, and PKC epsilon in SH-SY5Y cells. Values are expressed as % of
controls. C: control; PKC+: PKC activation by phorbol 12-myristate 13-acetate (5 μM); PKC−: PKC inhibition by Ro 31-0432 (5 μM);
CDCA: chenodeoxycholic acid (80 μM); CDCA/bilirubin: CDCA (80 μM)+ bilirubin (1 μM). ∗P < 0 05 vs. C; †P < 0 05 vs. CDCA.
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in glycosphingolipids and, for the comparison, the human
hepatoblastoma HepG2 cell line. Interestingly, the HepG2
cell line was found to be very poor in ganglioside content
and completely lacking GD3 synthase. Exposure of SH-SY5Y
to oxidative stress induced by chenodeoxycholic acid [55]
resulted in a signiﬁcant increase in all major gangliosides
of this cell line—GD1a, GM3, and GM2—while addition of
a potent antioxidant, bilirubin [56], resulted in normaliza-
tion of the ganglioside content. Importantly, the same pat-
tern was observed in the HepG2 cell line in GM3 and
GM2 gangliosides. These results are in accordance with
our earlier observations [10] that bilirubin may counteract
a prooxidative eﬀect of BA on hepatocytes in the model of
obstructive cholestasis in rats. Furthermore, accumulation
of hydrophobic BA in the brain and their possible involve-
ment in hepatic encephalopathy associated with cholestatic
liver diseases has been reported [57]. BA can act as cell
signalling eﬀectors through binding and activating receptors
on both the cell membrane and nucleus. BA signalling
encompasses both direct (FXR, TGR5) and indirect
(FGF19, GLP-1) pathways. The role of BA in extrahepatic
diseases is becoming more important, and increasing
amount of reports suggests that BA might play an important
role in neurological function and diseases [58, 59].
To elucidate the mechanism of oxidative stress-induced
changes of ganglioside metabolism, we focused on regulation
of the main enzyme in complex ganglioside synthesis, GM3
synthase (ST3GalV).
PKC appeared to be a logical candidate regulating the
expression of GM3 synthase. Hydrophobic bile acids are con-
sidered potent inducers of PKC while antioxidants inhibit
PKC activity [60, 61]. For more than 30 years, it has been
known that ganglioside metabolism is in tight connection
to PKC activity [62–64], and the action of glycosyltransfer-
ases is controlled through posttranslational modiﬁcation.
Glycosyltransferase activities have been demonstrated to be
signiﬁcantly modulated by the action of PKC [65]. Another
study suggested the role of PKC as an activator of GM3 syn-
thase (ST3GalV) [66]. Our in vitro data support this hypoth-
esis. While PKC activators and oxidative stress induced the
expression of ST3GalV, PKC inhibitors as well as antioxi-
dants completely abolished this eﬀect.
There are some limitations of our study. First, wewere pri-
marily interested in the shift of GSL to the cytoplasmic mem-
brane; however, more studies are needed to assess whether
subcellular localization and traﬃcking of gangliosides are
aﬀected as well. Second, in histochemical analyses, we used
GM1 as a GSL representative but further studies with individ-
ual gangliosides are needed to conﬁrm that the shift of GM1
from the intracellular compartment to the cytoplasmic mem-
brane is a general reaction to loss ofHmox1 action. Finally, the
PKC pathway is an important but probably not the only path-
way regulating GSL metabolism aﬀected by oxidative stress.
5. Conclusions
We conclude that oxidative stress is an important factor
modulating synthesis and distribution of gangliosides
in vivo and in vitro. Knockout of Hmox1, an important
antioxidant enzyme, results in tissue-speciﬁc increases in
main gangliosides together with changes inmRNAexpression
of key enzymes of ganglioside synthesis. We demonstrate that
these changes might be, at least partially, mediated through
modulation of the PKC pathway.
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